David Hong, MD of MD Anderson Cancer Center @MDAndersonNews discusses at this year’s virtual AACR the efficacy and safety of larotrectinib in patients with cancer and NTRK gene fusions or other alterations.
Advertisement
David Hong, MD on Outcomes of Larotrectinib in Patients with Cancer and NTRK Gene Fusions @MDAndersonNews #AACR2020
By Editor